Pharmaceutical Sciences Advisory Committee
Executive Summary
Two new working groups under the FDA committee's Nonclinical Studies Subcommittee will investigate potential biomarkers to predict drug induced cardiac tissue injury and drug induced vasculitis, FDA announces July 26. The Federal Register notice seeks nominations for working group members